VSTM
Verastem, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.62
−0.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.94x
- Price / sales
- 11.96x
- Price / cash flow
- -6.45x
Enterprise value
- Enterprise value
- $994.6M
- EV / sales
- 11.36x
- EV / EBITDA
- -4.98x
- EV / EBIT
- -6.22x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026